Results 221 to 230 of about 774,570 (356)
International Price Discovery in Stock Markets - A Unique Intensity Based Information Share
Kerstin Kehrle, Franziska J. Peter
openalex +1 more source
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon +13 more
wiley +1 more source
Academic Fatigue of Young Researchers: The Price of the Publish or Perish Culture. [PDF]
González Flores JE.
europepmc +1 more source
LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix +13 more
wiley +1 more source
Fairness modeling for topics with different scales in short texts. [PDF]
Zhu C, Liang Y, Liang X, Zhong L, Xie F.
europepmc +1 more source
Analysis of Price Discovery Effect in the Single Stock Futures Market
Woo‐Baik Lee
openalex +1 more source
Ted C Schroeder, J Mintert
openaire +2 more sources
Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla +10 more
wiley +1 more source
GLP-1 agonist, semaglutide use in acute pulmonary embolism recovery: a four-week proof-of-concept study including proteomic profiling. [PDF]
Samaranayake CB +17 more
europepmc +1 more source
Price discovery in spot and futures markets: a reconsideration
Erik Theissen
openalex +2 more sources

